Physician profile
Aman Sharma
NPI 1083278055
$11,393.56
in general payments reported to CMS, 2019-2025
5 companies · $6,764 in 2025
The $6,764 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43.20 · 2023: $25.77 · 2024: $4,561 · 2025: $6,764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,000 · Food and Beverage: $2,670 · Travel and Lodging: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,000.00 |
| Food and Beverage | $2,670.37 |
| Travel and Lodging | $1,679.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,747.12 | 2020-2025 | Journey II, Real Intelligence, Legion Revision |
| Zimmer Biomet Holdings, INC. | $3,164.23 | 2024-2025 | Persona, Comprehensive Shoulder System, Avenir |
| Stryker Corporation | $297.71 | 2024-2025 | T2, Mako, Pangea |
| Orthalign INC | $158.73 | 2024 | Orthalign Plus |
| Medtronic, INC. | $25.77 | 2023 | Aquamantys(Tm) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.